ENSG vs NVS
Ensign Group vs Novartis AG — AI-powered side-by-side comparison
| Metric | ENSG | NVS |
|---|
| AI Score |
68
|
73
|
| Price |
$182.93
|
$156.34
|
| P/E Ratio |
27.85×
|
23.66×
|
| ROE |
15.4%
|
30.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.1%
|
74.3%
|
| Debt / Equity |
0.92×
|
1.18×
|
| Dividend Yield |
0.1%
|
2.9%
|
| RSI (14) |
70.0
|
55.8
|
| Beta |
0.689
|
0.46
|
| Expected Upside |
+5.9%
|
+2.7%
|
AI Committee View
Current Innellis committee reasoning for ENSG versus NVS.
NVS leads by 5 points.
NVS scores 73/100 (Buy) versus ENSG at 68/100 (Buy).
ENSG Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
NVS Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical